![NATA](https://nata.com.au/files/2021/02/nata.png)
National Association of Testing Authorities, Australia
Scope of Accreditation
Proteomics International Pty Ltd
Site
WA Proteomics Facility
Accreditation No.
16838
Site No.
18237
Date of Accreditation
16 Jul 2009
Address
Harry Perkins Institute of Medical Research, Level 1 QQ Block, QEII Medical Centre, 6 Verdun Street
Nedlands, WA 6009
Australia
Contact
Availability
Services available to external clients
Scope of Accreditation
ISO/IEC 17025 (2017)
Food and Beverage
Service | Product | Determinant | Technique | Procedure |
---|---|---|---|---|
Analysis of physical and nutritional characteristics | Liquid milk; Milk concentrates; Milk powder; Milk protein concentrate; Milk protein isolate | A2 milk protein | HPLC | A2 Protein Determination in Client Supplied Milk Samples (in-house method 0-036) |
ISO/IEC 17025 (2017)
Healthcare, Pharmaceutical and Media Products
Service | Product | Determinant | Technique | Procedure | |
---|---|---|---|---|---|
Analysis for physical and chemical characteristics of human and veterinary medicines including vaccines | Biological or environmental sample containing protein; Pharmaceutical preparations; Protein derivative and small molecule (<900 Daltons) in liquid and solid format | Physiochemical tests | Gel electrophoresis; HPLC; LC-MS; UV-vis spectrophotometry | Protein ID (in-house method 1-012) LC-MS De Novo Seq (in-house method 1-012) LC-MS Proteome Mapping (in-house method 1-016) LC-MS 1-D Gel Electrophoresis (in-house method 2-004) Intact Mass Analysis (in-house method 1-016) LC-MS N-terminal Sequencing (in-house method 1-012) LC-MS Disulfide Bridge (in-house method 1-012) LC-MS N-Glycan Analysis (in-house method 0-048) Electrophoresis Isoelectric Focusing IEF (in-house method 2-010) Electrophoresis UV Vis/Fluorescent Spectral Analysis (in-house method 0-040) Charge Variant Analysis WCX (in-house method 3-001) HPLC Hydrophobic Interaction (in-house method 3-001) HPLC Chromatography HIC (in-house method 3-001) HPLC Size Exclusion SEC (in-house method 3-001) HPLC Pharmacokinetic Monitoring (in-house method 1-005, 1-015) LC-MS Proteome Quantitation (in-house method 1-016) LC-MS Targeted Analysis MRM/SRM (in-house method 1-015, 1-017. 1-018) LC-MS | |
Analysis in support of clinical trials and/or pre-clinical studies | Animal biological samples; Human biological samples | Development of biomarkers; Therapeutic drug discovery | Electrophoresis; HPLC; LC-MS; MALDI-TOF | ||
Analysis in support of research | Biological samples; Human biological samples; Liquid pharmaceutical preparations; Recombinant molecules; Solid pharmaceutical preparations | Discovery and development of biomarkers and biosimilars; Physiochemical characterisation; Therapeutic drug discovery | Electrophoresis; HPLC; LC-MS; MALDI-TOF | ||
Analysis in support of the development and/or optimisation of new assays, devices or techniques | Biological samples; Human biological samples; Liquid pharmaceutical preparations; Recombinant molecules; Solid pharmaceutical preparations | Development of biomarkers and biosimilars; Physiochemical characterisation; Therapeutic drug discovery | Electrophoresis; HPLC; LC-MS; MALDI-TOF | ||
Bioinformatic analysis and interpretation | Protein quantitation data from LC-MS analysis; Protein sequencing data from LC-MS analysis | Data annotation and interpretation; Differential biomarker identification | Bioinformatic analysis - Protein identification and relative protein expression software | in-house method 1-008, 7-006, 8-004, 8-006, 8-007, 8-008 | |
Biological analysis of other healthcare or pharmaceutical products and accessories | Biological or environmental sample containing protein; Protein derivative and small molecule (<900 Daltons) in liquid and solid format | Physicochemical tests | Electrophoresis; HPLC; LC-MS; Mass spectrometry (MS) |
|
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
16838
Site No.
18237
Print date
31 Aug 2024